Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Numinus Wellness Inc NUMIF


Primary Symbol: T.NUMI

Healthcare
Numinus Wellness Inc. is a mental health care company. The Company focuses on advancing traditional and behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies. Its segments include Clinical research operations, Practitioner Training, Clinic network, and Corporate. Clinical research operations segment is focused on licensed psychedelic research and... see more

Recent & Breaking News (TSX:NUMI)

Numinus to Host Q4 and Year End 2022 Results Conference Call on November 29, 2022

Canada NewsWire November 15, 2022

Numinus Re-Launches "Psychedelic Therapy Frontiers" Podcast with additional hosts and topics

PR Newswire November 1, 2022

Numinus to Participate in Wonderland: Miami on November 3-5, 2022

PR Newswire October 31, 2022

Numinus (TSX:NUMI) Launches Psychedelic-Assisted Therapy for Chronic and Serious Medical Illness

Caroline Egan  October 28, 2022

Numinus Launches Psychedelic-Assisted Therapy for Chronic and Serious Medical Illness

PR Newswire October 28, 2022

Numinus to Participate in a Water Tower Research Fireside Chat on Thursday, October 13, 2022

PR Newswire October 7, 2022

Numinus Develops Mushroom Tea for Use in Psychedelic Research

PR Newswire October 5, 2022

Numinus to Participate in the Cantor Neurology & Psychiatry Conference on October 6-7, 2022

PR Newswire September 29, 2022

Numinus (TSX:NUMI) expands ketamine therapy

Caroline Egan  September 22, 2022

Numinus Expands Ketamine Therapy for Mental Health in Montreal and announces new brand awareness initiatives

PR Newswire September 22, 2022

Numinus' (TSX:NUMI) ketamine therapy now available in Toronto

Caroline Egan  September 19, 2022

Numinus Now Offers Ketamine-Assisted Therapy in Toronto

PR Newswire September 19, 2022

Numinus provides update on acquisition integration and announces new client financing options

PR Newswire September 13, 2022

Numinus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022

PR Newswire August 31, 2022

Numinus Wellness Inc. Reports Q3 2022 Results

PR Newswire July 14, 2022

Numinus to Host Q3 2022 Results Conference Call on July 14, 2022

PR Newswire July 6, 2022

Numinus Unveils New Logo and Brand Identity

PR Newswire June 27, 2022

Numinus Pilots Mental Health Program for Corporate Clients in Utah

PR Newswire June 23, 2022

Numinus Applies for International Patent Filing of Psychedelics Production Process

PR Newswire June 22, 2022

Numinus to Participate in the H.C. Wainwright 1st Annual Mental Health Conference on June 27, 2022

PR Newswire June 21, 2022